UNITED THERAPEUTICS Corp financial data

Symbol
UTHR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1000 Spring St, Silver Spring, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 428 % -54.9%
Quick Ratio 14.6 % -50.5%
Debt-to-equity 20.6 % -17.5%
Return On Equity 18.8 % +7.36%
Return On Assets 15.6 % +11.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.5M shares -5.2%
Common Stock, Shares, Outstanding 44.4M shares -5.31%
Entity Public Float 9.14B USD -13.2%
Common Stock, Value, Issued 700K USD 0%
Weighted Average Number of Shares Outstanding, Basic 44.4M shares -5.33%
Weighted Average Number of Shares Outstanding, Diluted 47.5M shares -4.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.62B USD +24%
Research and Development Expense 480M USD +44.6%
Costs and Expenses 1.35B USD +32.3%
Operating Income (Loss) 1.26B USD +16.1%
Nonoperating Income (Expense) 138M USD +349%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.4B USD +25.3%
Income Tax Expense (Benefit) 332M USD +34.3%
Net Income (Loss) Attributable to Parent 1.07B USD +22.7%
Earnings Per Share, Basic 23.1 USD/shares +22.6%
Earnings Per Share, Diluted 21.7 USD/shares +23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.36B USD +27%
Marketable Securities, Current 1.62B USD +0.25%
Accounts Receivable, after Allowance for Credit Loss, Current 291M USD +6.6%
Inventory, Net 137M USD +32.1%
Other Assets, Current 221M USD +39.4%
Assets, Current 3.62B USD +12.6%
Deferred Income Tax Assets, Net 396M USD +21.5%
Property, Plant and Equipment, Net 1.09B USD +16.6%
Operating Lease, Right-of-Use Asset 12.2M USD
Goodwill 33.7M USD +20.4%
Other Assets, Noncurrent 168M USD +24.1%
Assets 6.72B USD +0.63%
Accounts Payable, Current 5.6M USD +36.6%
Employee-related Liabilities, Current 72.9M USD +9.62%
Accrued Liabilities, Current 292M USD +29.5%
Liabilities, Current 832M USD +125%
Other Liabilities, Noncurrent 93.7M USD -6.3%
Liabilities 1.03B USD -19.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14.9M USD +70.6%
Retained Earnings (Accumulated Deficit) 6.61B USD +19.3%
Stockholders' Equity Attributable to Parent 5.7B USD +5.29%
Liabilities and Equity 6.72B USD +0.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 377M USD +0.45%
Net Cash Provided by (Used in) Financing Activities -1.07B USD -2298%
Net Cash Provided by (Used in) Investing Activities 735M USD
Common Stock, Shares Authorized 245M shares 0%
Common Stock, Shares, Issued 74.5M shares +1.31%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.8M USD -78.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.36B USD +27%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.6M USD -3.82%
Deferred Tax Assets, Valuation Allowance 30.8M USD +37.5%
Deferred Tax Assets, Gross 468M USD +19.7%
Operating Lease, Liability 12.2M USD
Payments to Acquire Property, Plant, and Equipment 38.2M USD -7.51%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.11B USD +24.7%
Lessee, Operating Lease, Liability, to be Paid 32.8M USD +3.47%
Property, Plant and Equipment, Gross 1.56B USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.3M USD +22.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.7M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.2M USD +20%
Deferred Tax Assets, Operating Loss Carryforwards 21.4M USD +125%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 24.1M USD +58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.2M USD +20%
Depreciation, Depletion and Amortization 15M USD +12.8%
Deferred Tax Assets, Net of Valuation Allowance 437M USD +18.6%
Share-based Payment Arrangement, Expense 113M USD +77.1%
Interest Expense 58.8M USD +41.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%